Realbotix Corp. (XBOTF)
(Delayed Data from OTC)
$0.08 USD
0.00 (-1.32%)
Updated Sep 11, 2024 03:49 PM ET
5-Strong Sell of 5 5
F Value D Growth A Momentum F VGM
Income Statements
Fiscal Year end for Realbotix Corp falls in the month of September.
All items in Millions except EPS data.
9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 | |
---|---|---|---|---|---|
Sales | 1 | NA | NA | NA | NA |
Cost Of Goods | 0 | NA | NA | NA | NA |
Gross Profit | 1 | NA | NA | NA | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 6 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -6 | 0 | 0 | 0 | 0 |
Non-Operating Income | -5 | NA | NA | NA | NA |
Interest Expense | 0 | NA | NA | NA | NA |
Pretax Income | -10 | NA | NA | NA | NA |
Income Taxes | 0 | NA | NA | NA | NA |
Minority Interest | 0 | NA | NA | NA | NA |
Investment Gains/Losses | 0 | NA | NA | NA | NA |
Other Income/Charges | 0 | NA | NA | NA | NA |
Income From Cont. Operations | -10 | NA | NA | NA | NA |
Extras & Discontinued Operations | 0 | NA | NA | NA | NA |
Net Income (GAAP) | -10 | NA | NA | NA | NA |
Depreciation Footnote | 9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -6 | 0 | 0 | 0 | 0 |
Depreciation & Amortization (Cash Flow) | 0 | NA | NA | NA | NA |
Income After Depreciation & Amortization | -6 | 0 | 0 | 0 | 0 |
Earnings Per Share Data | 9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 |
---|---|---|---|---|---|
Average Shares | 104.71 | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.04 | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | -0.09 | NA | NA | NA | NA |
Fiscal Year end for Realbotix Corp falls in the month of September.
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.31 | 0.29 | 0.22 | 0.16 | 0.13 |
Cost Of Goods | NA | 0.00 | 0.02 | 0.02 | 0.04 |
Gross Profit | NA | 0.29 | 0.20 | 0.14 | 0.09 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | -3.50 | -1.88 | 4.68 | 1.08 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 3.79 | 2.08 | -4.54 | -0.99 |
Non-Operating Income | NA | 0.03 | 0.04 | 0.48 | 0.08 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | 3.82 | 2.12 | -9.26 | -0.90 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | -0.01 | 0.00 | 0.40 | -0.21 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -2.50 | 3.82 | 2.12 | -9.26 | -0.90 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -2.50 | 3.83 | 2.12 | -9.66 | -0.69 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 181.12 | 124.33 | 119.76 | 104.71 | 103.58 |
Diluted EPS Before Non-Recurring Items | -0.01 | 0.00 | 0.00 | -0.03 | -0.01 |
Diluted Net EPS (GAAP) | -0.01 | 0.03 | 0.02 | -0.08 | -0.01 |